Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 23;24(1):1457.
doi: 10.1186/s12879-024-10385-1.

Non-linear effects of age in reporting of adverse events following influenza immunization in Zhejiang, China

Fuxing Chen #  1 , Yaping Chen #  1 , Hui Liang  1 , Xuejiao Pan  1 , Ying Wang  1 , Lingzhi Shen  1 , Yu Hu  2
Affiliations

Non-linear effects of age in reporting of adverse events following influenza immunization in Zhejiang, China

Fuxing Chen et al. BMC Infect Dis. .

Abstract

Background: Previous evidence had suggested age and sex affect the reporting rate of adverse events following immunization (AEFI), but with little exploration of potential their non-linear and interaction effects on AEFIs. Examining these non-linear effects could be beneficial for identifying high-risk populations.

Methods: Using AEFI records and vaccination data from national passive surveillance system of adverse event following immunization and Zhejiang provincial immunization information system in the 2021-2022 influenza season, respectively. The effects of age and sex on AEFIs were analyzed through the generalized additive model (logistic regression with a smooth term) to estimate non-linear characteristics after adjusting for other co-variables (adopted significance level p < 0.05).

Results: There were 1,259,975 influenza vaccine doses administered and 1304 AEFI records reported during the 2021-2022 influenza season, with a reporting rate of 10.35/10,000 doses. The odds of reporting an AEFI increased from 6 months of age, peaking at about 54 years of age, then gradually declined. The odds of females experiencing AEFIs are higher than that of males. The data model indicated clear effects of age, sex, and their interaction (p < 0.01) on reporting rate of AEFI. Concomitant vaccination and vaccine type were also the impact factors for reporting rate of AEFI.

Conclusion: This study revealed a non-linear property in age and the AEFI odds, with a significant interaction and higher reporting rate in females. In addition, the odds of AEFI increased with co-administration compared to separate vaccination.

Keywords: Adverse events following immunization; Age; Influenza vaccine; Interactions; Non-linear effects.

PubMed Disclaimer

Conflict of interest statement

Declarations. Institutional review board statement: The study was approved by the Institutional Ethics Committees of Zhejiang provincial center for disease control and prevention (TR-027). No personal information, including the names of specific participants involved in the monitoring, will be disclosed. Written informed consent from the participants or legal guardians were not required for participation in this study according to national legislation and institutional requirements [29]. Informed consent: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Average marginal effect of age on aOR of the AEFI following influenza between sexes using GAM. The figure illustrated the aOR across age stratified by sex. Solid lines denoted the average marginal aOR and shaded regions indicated the 95% CI
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285–300. - PMC - PubMed
    1. Kahn R, Rid A, Smith PG, Eyal N, Lipsitch M. Choices in vaccine trial design in epidemics of emerging infections. PLoS Med. 2018;15(8):e1002632. - PMC - PubMed
    1. Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP. Active surveillance for adverse events following immunization. Expert Rev Vaccines. 2014;13(2):265–76. - PubMed
    1. Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013;9(8):1763–73. - PMC - PubMed
    1. Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):9–15. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources